SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899866-21-000048
Filing Date
2021-06-09
Accepted
2021-06-09 16:50:22
Documents
1
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162327180875734.html 4  
1 FORM 4 wf-form4_162327180875734.xml 4 3360
  Complete submission text file 0000899866-21-000048.txt   4831
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Issuer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ALEXION PHARMACEUTICALS, INC 100 COLLEGE STREET NEW HAVEN CT 06510
Business Address
Franchini Indrani Lall (Reporting) CIK: 0001708764 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-27756 | Film No.: 211005654